TrialDiabetes, obesity & metabolism2018

Glycaemic control and hypoglycaemia in people with type 2 diabetes switching from twice-daily basal insulin to once-daily insulin glargine 300 U/mL or insulin glargine 100 U/mL (EDITION 1 and EDITION 2 subgroup analysis).

Ronan Roussel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.